Document is current
Any future updates will be listed below
-
Authors
Cipolletta, Edoardo
Smerilli, Gianluca
Mirza Mashadi, Riccardo
Mandl, Peter
Filippucci, Emilio
- License Information
-
More Information
Article History
Received: 9 October 2024
Accepted: 17 February 2025
First Online: 26 February 2025
Declarations
:
: The study protocol was approved by the local ethics committee (id CERM: 262/2019) of the Comitato Etico Unico Regione Marche. Patients have signed their consent to participate in the study.
: Not applicable.
: The authors declare that they have not used any type of generative artificial intelligence for the writing of this manuscript, nor for the creation of images, graphics, tables, or their corresponding captions.
: EC has received research grant from FOREUM and EULAR, speaking fees from IBSA, and Novartis, outside the submitted work. EF has received speaking fees from AbbVie, Bristol-Myers Squibb, Celgene, Novartis, Pfizer, Roche and Union Chimique Belge Pharma, outside the submitted work. PM has received speaking fees from AbbVie, Janssen, Novartis and Sobi, and grant support by AbbVie, Alfasigma, Novartis and UCB. All other authors have declared no conflict of interest.
